PharmiWeb.com - Global Pharma News & Resources
25-Jul-2024

Coulter Partners - Top hires for VC & PE portfolio companies Q2-2024

Summary

Search Highlights Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
Editor: Christelle Kerouedan Last Updated: 10-Oct-2024

This quarter’s successful placements include:

Function

Focus area

Location

CEO

Vaccine technologies

France

CEO

Antibody therapeutics

US

CEO

Interventional devices

Switzerland

CEO

Protein alternatives

US

Chief Business Officer

Immuno-oncology platform

UK

Chief Commercial Officer

Drug discovery services

Germany

Chief Financial Officer

Digital implant solutions

Switzerland

VP Global Sales & Marketing Strategy

Medical devices

Ireland

Chief Medical Officer

siRNA technology

US

Chief Medical Officer

Small molecule therapies

Italy

VP Business Development, Cell Therapy

Precision medicines

UK

Head of Preclinical

Monoclonal antibodies

UK

Head of Commercial US

Functional assays

Sweden

CMC Director

Peptide therapeutics

France

Board Directors

Small molecule biopharma

Australia

Scientific Operating Partner

VC investor

UK

 

 

Newly opened projects include:

Function

Focus area

Location

CEO

Medical devices

Israel

CEO

Antibody therapeutics

Benelux

Chief Commercial Officer

Computational discovery services

UK

Chief Financial Officer

Antibody based therapeutics

Denmark

Chief Scientific Officer

AI platform technologies

UK

Chief Technology Officer

Remote monitoring

France

VP Business Development

Inflammation therapeutics

UK

VP Global Head of Sales

Drug discovery

US

VP Head of R&D

Mitochondrial medicine

UK

Program Director

SaaS solutions for pharma

Benelux

Managing Partner

Life sciences consultancy services

US

Partner

Healthcare communications

UK

Chair

Protein alternatives

UK

Board Directors

Generics

Spain